PAS
Point72 Asia (Singapore) Portfolio holdings
AUM
$563M
1-Year Return
23.62%
This Quarter Return
+4.11%
1 Year Return
+23.62%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$409M
AUM Growth
–
Cap. Flow
+$409M
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
50.99%
Holding
569
New
568
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
Chevron
CVX
|
$48.9M |
| 2 |
Invesco QQQ Trust
QQQ
|
$29.8M |
| 3 |
Williams Companies
WMB
|
$23.5M |
| 4 |
SPDR S&P 500 ETF Trust
SPY
|
$22.4M |
| 5 |
Exxon Mobil
XOM
|
$19.6M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Energy | 47.74% |
| 2 | Technology | 14.88% |
| 3 | Utilities | 4.68% |
| 4 | Financials | 3.62% |
| 5 | Consumer Discretionary | 2.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
526
Universal Electronics
UEIC
$64M
| $5.63K | ﹤0.01% |
+600
| New | +$5.63K |
|
527
Design Therapeutics
DSGN
$331M
| $5.57K | ﹤0.01% |
+2,100
| New | +$5.57K |
|
528
Bioventus
BVS
$482M
| $5.5K | ﹤0.01% |
+1,044
| New | +$5.5K |
|
529
Upland Software
UPLD
$67.6M
| $5.44K | ﹤0.01% |
+1,285
| New | +$5.44K |
|
|
QVCGA
530
QVC Group, Inc. Series A Common Stock
QVCGA
$79M
| $5.43K | ﹤0.01% |
+124
| New | +$5.43K |
|
|
KNTE
531
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
| $5.21K | ﹤0.01% |
+2,200
| New | +$5.21K |
|
532
Telefonica
TEF
$30.2B
| $5.07K | ﹤0.01% |
+1,300
| New | +$5.07K |
|
533
Matrix Service
MTRX
$406M
| $4.89K | ﹤0.01% |
+500
| New | +$4.89K |
|
534
First Internet Bancorp
INBK
$215M
| $4.84K | ﹤0.01% |
+200
| New | +$4.84K |
|
|
LL
535
DELISTED
LL Flooring Holdings, Inc.
LL
| $4.65K | ﹤0.01% |
+1,192
| New | +$4.65K |
|
536
Western New England Bancorp
WNEB
$251M
| $4.45K | ﹤0.01% |
+494
| New | +$4.45K |
|
537
Columbia Banking Systems
COLB
$8.06B
| $4.12K | ﹤0.01% |
+154
| New | +$4.12K |
|
|
USAP
538
DELISTED
Universal Stainless & Alloy
USAP
| $4.02K | ﹤0.01% |
+200
| New | +$4.02K |
|
539
Everspin Technologies
MRAM
$152M
| $4.01K | ﹤0.01% |
+443
| New | +$4.01K |
|
540
Seres Therapeutics
MCRB
$200M
| $4K | ﹤0.01% |
+143
| New | +$4K |
|
|
VXRT
541
DELISTED
Vaxart
VXRT
| $3.95K | ﹤0.01% |
+6,900
| New | +$3.95K |
|
542
Gannett
GCI
$610M
| $3.9K | ﹤0.01% |
+1,695
| New | +$3.9K |
|
543
Puma Biotechnology
PBYI
$230M
| $3.88K | ﹤0.01% |
+896
| New | +$3.88K |
|
544
AXT Inc
AXTI
$143M
| $3.84K | ﹤0.01% |
+1,600
| New | +$3.84K |
|
545
Lyra Therapeutics
LYRA
$10.9M
| $3.42K | ﹤0.01% |
+13
| New | +$3.42K |
|
546
Inovio Pharmaceuticals
INO
$153M
| $3.42K | ﹤0.01% |
+558
| New | +$3.42K |
|
547
Tredegar Corp
TG
$274M
| $3.25K | ﹤0.01% |
+600
| New | +$3.25K |
|
548
Spire Global
SPIR
$278M
| $3.2K | ﹤0.01% |
+409
| New | +$3.2K |
|
549
Inotiv
NOTV
$55M
| $2.94K | ﹤0.01% |
+800
| New | +$2.94K |
|
550
American Public Education
APEI
$583M
| $2.9K | ﹤0.01% |
+300
| New | +$2.9K |
|